ANNIE PETIT-HOMME: Open Payments
NPI 1508528464 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 12 payments from 10 companies in 2025. Trend: 2023 $1,958 · 2024 $907 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $157 |
| Syndax Pharmaceuticals, Inc. | 1 | $127 |
| Merck Sharp & Dohme LLC | 1 | $120 |
| JAZZ PHARMACEUTICALS INC. | 1 | $98 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Caris MPI, Inc. | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: ICLUSIG, REVUFORJ, KEYTRUDA, ZEPZELCA, TAVALISSE, ENHERTU, MI CANCER SEEK, RYBREVANT.
Industry payments across WA — which companies pay providers there.
